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of the exome was affected by CNVs
in KNSTRN-mutated tumors versus 1.4%
(SD 3.0%) in KNSTRN-wild-type tumors
(P=0.74). Although this was not statisti-
cally signiﬁcant, our ability to detect
differences may have been limited by a
small sample size.
In SCC, KNSTRN p.S24F is present in
19% of tumor precursors, suggesting
that it arises early in disease progression
(Lee et al., 2014). To determine whether
KNSTRN mutagenesis is an early event in
BCC development as well, we screened
30 early stage BCCs for KNSTRN
mutations. We identiﬁed a nonsynony-
mous KNSTRN mutation in only 1/30
(3%) early stage BCCs, suggesting that,
unlike in SCC, mutant KNSTRN in BCC
appears to be acquired later in disease
and is possibly a marker of aggressive
behavior (Figure 1c and f). The mutation,
pH284D, is absent from dbSNP137 and
ESP6500 and is predicted to be deleter-
ious by SIFT; however, it has not pre-
viously been reported in the COSMIC
database and is not predicted to be
damaging by Polyphen.
These ﬁndings are the ﬁrst to impli-
cate KNSTRN in BCC tumorigenesis.
Alongside recent data offering a role
for KNSTRN in SCC and melanoma,
our work supports the classiﬁcation
of KNSTRN as an oncogene and
an important contributor to the patho-
genesis of malignancies related to
UV-exposure. In both SCC and BCC,
mutant KNSTRN disrupts sister chroma-
tid cohesion and promotes genomic
instability in functional assays. How-
ever, unlike in SCC, KNSTRN muta-
tions in BCC appear to occur late in
disease progression and are preferen-
tially found in advanced tumors. Further
exploration of the role of KNSTRN in
skin cancer and genomic stability is
warranted.
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TO THE EDITOR
Declining estrogen levels in postmeno-
pausal women are related to delayed
wound healing. It is known that estro-
gen inﬂuences skin re-epithelialization
(Ashcroft et al., 1997) and may promote
skin wound healing via estrogen
receptor-β (ER-β Campbell et al.,
2010). However, the cellular and
subcellular mechanisms of estrogen’s
action on keratinocyte migration are
still poorly understood. Epithelial–
mesenchymal transition (EMT) is an
important process in which epithelial
cells lose their epithelial characteristics
and acquire mesenchymal traits. This
signiﬁcant phenotypic conversion leads
to the acquisition of motile behavior. In
the skin, EMT has been shown to have a
role in skin morphogenesis (Kong et al.,
2006), skin cancers (Shimokawa et al.,
2013; Wong et al., 2013; MagnoniAccepted article preview online 20 August 2015; published online 24 September 2015
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et al., 2014; Qu et al., 2014), wound
healing (Savagner et al., 2005; Arnoux
et al., 2008; Hudson et al., 2009), and
skin ﬁbrosis (Postlethwaite et al., 2004;
Takahashi et al., 2013). In this study, we
tested the hypothesis that estrogen-
induced acceleration of wound healing
is mediated by EMT during keratinocyte
migration. This study was approved by
the institutional review board and writ-
ten informed consent was obtained
from all subjects before they partici-
pated in the study. All experimental
details are given in Supplementary
Materials and Methods online.
As the expression of ER in human skin
remains contentious, the expression of
ERs in HaCaT (immortalized human
skin keratinocyte cell line) cells and
primary human keratinocytes (PHK) was
analyzed by immunoﬂuorescence.
T47D, a human ductal breast epithelial
tumor cell line, was used as a positive
control of ERs. Whereas expression of
both ER-α and ER-β was observed in
T47D cells, HaCaT cells, and PHK
expressed only ER-β (Supplementary
Figures S1a and c online). The effect of
17β-estradiol (E2) treatment on viability
of HaCaT cells was measured using an
MTT assay. Although E2 had little effect
on cell viability at lower concentrations,
there was a statistically signiﬁcant reduc-
tion in cell viability after treatment with
1 μM E2 (Po0.0001, Supplementary
Figure S1d online).
To investigate the role of EMT in
E2-induced keratinocyte migration, we
ﬁrst analyzed whether E2 could mod-
ulate the expression of EMT-biomarkers.
HaCaT cells were cultured to 80% of
conﬂuency and then incubated with
0.1, 1, 10, 100 nM, or 1,000 nM E2 for
48 h. We found that concentrations of
E2 ranging from 1 to 100 nM signiﬁ-
cantly induced the expression of Slug,
Twist, and vimentin and signiﬁcantly
repressed the expression of E-cadherin,
whereas treatment with 1,000 nM E2
had little or no effect (Figure 1a and
b). We next utilized ICI, a potent ER
antagonist, and G15, an antagonist of
another estrogen-related receptor,
GPR30, to evaluate the E2 mechanism
of action on HaCaT cells. E2 altered
expression of the EMT-biomarkers, Slug,
Twist, vimentin, and E-cadherin, was
reversed following treatment with ICI;
however, G15 could not abrogate the
changes in expression of EMT-biomarkers
(Figure 1c). These data indicate that
estrogen regulates expression of
EMT-related molecules through ERs but
not GPR30. Next, to determine the role of
Slug in the E2-dependent modulation of
EMT-related molecules, cells were trans-
fected with Slug siRNA before stimulation
with E2. We observed that expression of
E-cadherin was increased, whereas that
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Figure 1. Upregulated Slug, Twist, and vimentin and downregulated E-cadherin in HaCaT cells after treatment with E2. (a) Quantitative real-time PCR (qRT-
PCR) analysis of E-cadherin, vimentin, Slug, and Twist in HaCaT cells after treatment with 0.1, 1, 10, 100, and 1,000 nM E2 for 48 h. (b) Western blot analysis of
E-cadherin, vimentin, Slug, and Twist in HaCaT cells. (c) Estrogen receptor (ER) mediates E2-induced E-cadherin, vimentin, Slug, and Twist expression in
HaCaT cells. Inhibition of ER, but not GPR30, blocked E2-induced Slug, Twist, and vimentin messenger RNA (mRNA) expression. (d) Slug knockdown impairs the
migration of HaCaT cells. HaCaT cells were transfected with siRNA oligo speciﬁc for Slug (Slug siRNA) or a scrambled siRNA oligo (scrambled siRNA)
before stimulations with E2, and the migration of cells were assessed using scratch assay and are represented as percentage (%) of wound remaining open
(Scale bar= 100 μm). All results are representative or means± SD of three independent experiments. Differences were determined by one-way analysis of
variance (ANOVA) or two-way ANOVA. *Po0.05, **Po0.001 versus vehicle-treated or E2 100 nM-treated HaCaT cells.
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of vimentin was reduced (Supplementary
Figure S2 online), as compared with
scrambled siRNA control.
To investigate whether estrogen can
alter the rate of cell migration, a scratch
assay was performed. Conﬂuent mono-
layers of HaCaT cells were scratched
with a sterile P200 pipette tip, and
cellular debris was completely removed
by washing. Cells were then treated
with 0.1, 1, 10, or 100 nM E2, and
images of the same ﬁeld were captured
at 0, 24, 48, and 72 h after scratching.
As shown in Supplementary Figure S3a
online, HaCaT cells incubated with all
concentrations of E2 migrated toward
the center of the wound to a greater
extent than those treated with vehicle.
In order to conﬁrm results obtained
from the scratch assay, transwell assays
were performed. When various concen-
trations of E2 (0.1, 1, 10, and 100 nM)
were added to the lower chambers,
HaCaT cells in the upper chambers
signiﬁcantly migrated towards E2, as
compared with those treated with vehi-
cle (Supplementary Figure S3b online).
To further determine whether Slug is
involved in the E2-induced migration of
HaCaT cells, scratch assay after Slug
siRNA transfection was performed. The
migration of HaCaT cells was markedly
inhibited by transfection with Slug
siRNA, as compared with cells
transfected with scrambled siRNA con-
trol (Figure 1d). Collectively, these
results suggest a critical role for Slug-
mediated EMT in the E2-mediated
enhancement of keratinocyte migration.
Because HaCaT cells are immorta-
lized keratinocytes that may behave
differently from normal human skin,
we investigated the effects of E2 on
expression of Slug in an ex vivo skin
explant model. As the endogenous
estrogen levels and response to exogen-
ous estrogen are different depending on
subjects’ age and gender, skin explants
were obtained from postmenopausal
donors (Supplementary Table 1 online).
At 2 days post-treatment with 10 or
100 nM E2, epidermal thickness was
signiﬁcantly increased in E2-treated epi-
dermis compared with that in vehicle-
treated epidermis. (Figure 2). Immuno-
ﬂuorescence labeling together with con-
focal laser microscopy using speciﬁc
mABs revealed higher cellular expres-
sion of Slug and lower expression of
E-cadherin in the 10 nM E2-teated
(Figure 2, middle image) and 100 nM
E2-treated (Figure 2, lower image) epi-
dermis compared with vehicle-treated
skin control (Figure 2, upper image). In
addition, Slug was expressed mostly in
the lower epidermis of vehicle-treated
skin, however, it was expressed in the
entire epidermis of 10 nM E2- and
100 nM E2-treated skin. Also, at 2 days
post-treatment with 10 or 100 nM E2,
epidermal thickness was signiﬁcantly
increased in E2-treated epidermis com-
pared with that in vehicle-treated epi-
dermis (Supplementary Figure S4
online). This suggests that E2 can
modulate EMT in normal epidermis.
The Snail family of transcription fac-
tors is best known for its ability to trigger
EMT through repression of E-cadherin
(Batlle et al., 2000; Cano et al., 2000;
Bolos et al., 2003), which is important
for the strength of cellular adhesion in a
tissue and cellular motility. Savagner
et al. (2005) analyzed the expression of
Slug during wound healing using in situ
hybridization and reported a crucial
role for Slug in keratinocyte migration
in vitro. Hudson et al. (2009) also
showed that re-epithelialization of exci-
sional wound healing was signiﬁcantly
impaired in Slug-deﬁcient mice. In addi-
tion, EGF, the most potent effector of
keratinocyte migration, induced activa-
tion of ERK5 and upregulated Slug
(Arnoux et al., 2008).
The estrogen-induced molecular
changes demonstrated in this study are
consistent with changes seen during
EMT. Estrogen also accelerated kerati-
nocyte migration, and this effect was
lost in Slug knockdown cells. Our
data indicate that estrogen might
Slug
Vehicle
E2
10 nM
E2
100 nM
Slug + DAPI Twist Twist + DAPI E-cadherin E-cadherin + DAPI
Figure 2. Upregulated Slug and Twist, and downregulated E-cadherin in an ex vivo skin explant model after E2 treatment. Immunoﬂuorescence confocal
images were obtained for Slug (green), Twist (red), and E-cadherin (red) in vehicle-treated (upper), 10 nM E2-treated (middle), and 100 nM E2-treated (lower) skin.
The image is representative data of three independent experiments using nine skin explants obtained from two donors. Nuclei were stained with DAPI (blue).
Scale bar=50 μm.
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promote re-epithelialization in wound
healing via an EMT process. This high-
lights the possibility that further explor-
ing the role of estrogen-induced EMT in
the skin may yield novel insights into
critical processes such as aging, ﬁbrosis,
and cancer metastasis.
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